LOL, that's kind of what I was thinking. Also, in response to the past few posts stating that news didn't or wouldn't drive this...its one thing to expect good news, one thing to not rocket upwards after one of the three trials is wrapped up with good news;
I personally believe that having all three trials wrapped, with great efficacy news on all 3 indications, and ready to go into all 3 pivotal PIII trials, with (correct me if I'm wrong) all of them running concurrent, is another story all together. At that point we're in realistic time frame to NDA and the market will likely like that progress milestone. At least I'm hoping so!
Market Data 
Markets 
AI
